Topic Archives: GlycoMimetics (GLYC)

[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars! ¬†You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]

Comments

  • Avatar

    For several years from 12-99 through about 4 years ago, Amylin Pharmaceuticals was 50% of my total portfolio. During my...

  • Avatar

    Back to the title article, from Forbes we get: Want to Fight a Deadly Fungus? San Diego's Amplyx Just Got $41M For That...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info